Literature DB >> 25295808

Serum basal tryptase levels in healthy children: correlation between age and gender.

Umit Murat Sahiner1, S Tolga Yavuz, Betul Buyuktiryaki, Ozlem Cavkaytar, Ebru Arik Yilmaz, Ayfer Tuncer, Cansin Sackesen.   

Abstract

Tryptase is used as a marker in many clinical conditions such as mast cell activation and systemic anaphylaxis. Normal levels of the serum basal tryptase (sBT) are determined in adulthood; however, data about nonallergic healthy children is limited. This study was designed to determine the normal sBT levels in healthy children. Total sBT levels were measured in 113 sera from healthy nonallergic children, for routine follow-up or diagnosis of illnesses that are not known to induce changes in serum tryptase levels. One hundred thirteen children aged 0.16-9.91 years (male/female subjects, 68/45 [60%/40%]) with a median (interquartile) age of 3.36 years (1.94-5.68 years) were evaluated. The sBT level was determined to be 3.30 ng/mL (2.38-4.36) median (interquartile) for the whole group. There was a tendency of higher sBT levels for boys than girls (3.49 [2.56-4.64 ng/mL] and 2.91 ng/mL [2.16-4.16 ng/mL], respectively); however, these findings were not significant (p = 0.12). The analysis of the whole group revealed that sBT levels were inversely related with age (r = -0.259; p = 0.006); and the decrease of sBT with age was more prominent in girls (r = -0.282; p = 0.02) than in boys. The highest sBT levels were found in the 0- to 1-year age group (all, 4.67 ng/mL [4.04-6.39 ng/mL]; boys, 5.34 ng/mL [4.04-6.39 ng/mL]; girls, 4.48 ng/mL [3.23-16.26 ng/mL]). The sBT levels in healthy children are similar to those in adults except in infancy. Interestingly, sBT levels tend to decrease slightly with age. Although they did not reach significance, sBT levels were found to be higher in boys compared with the girls.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25295808     DOI: 10.2500/aap.2014.35.3769

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  5 in total

1.  United airway disease.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2014 Sep-Oct       Impact factor: 2.587

Review 2.  Future Research Directions in Asthma. An NHLBI Working Group Report.

Authors:  Bruce D Levy; Patricia J Noel; Michelle M Freemer; Michelle M Cloutier; Steve N Georas; Nizar N Jarjour; Carole Ober; Prescott G Woodruff; Kathleen C Barnes; Bruce G Bender; Carlos A Camargo; Geoff L Chupp; Loren C Denlinger; John V Fahy; Anne M Fitzpatrick; Anne Fuhlbrigge; Ben M Gaston; Tina V Hartert; Jay K Kolls; Susan V Lynch; Wendy C Moore; Wayne J Morgan; Kari C Nadeau; Dennis R Ownby; Julian Solway; Stanley J Szefler; Sally E Wenzel; Rosalind J Wright; Robert A Smith; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

3.  A Case Report of a 3-Year-Old Child With Anaphylactic Shock After a Diclofenac Suppository Confirmed by Serial Tryptase and a Basophil Activation Test.

Authors:  Wun-Yan Huang; Tsu-Man Chiu; Su-Feng Kuo; Wen-Hung Chung; Yi-Giien Tsai
Journal:  Front Pediatr       Date:  2022-02-17       Impact factor: 3.418

Review 4.  Estimating the within-subject (CVI ) and between-subject (CVG ) biological variation of serum tryptase.

Authors:  Birthe R Skarbø; Erik W Vinnes; Tore Wentzel-Larsen; Marit S Sylte; Torunn O Apelseth
Journal:  Immun Inflamm Dis       Date:  2021-12-13

5.  Mast cell hyperactivity underpins the development of oxygen-induced retinopathy.

Authors:  Kenshiro Matsuda; Noriko Okamoto; Masatoshi Kondo; Peter D Arkwright; Kaoru Karasawa; Saori Ishizaka; Shinichi Yokota; Akira Matsuda; Kyungsook Jung; Kumiko Oida; Yosuke Amagai; Hyosun Jang; Eiichiro Noda; Ryota Kakinuma; Koujirou Yasui; Uiko Kaku; Yasuo Mori; Nobuyuki Onai; Toshiaki Ohteki; Akane Tanaka; Hiroshi Matsuda
Journal:  J Clin Invest       Date:  2017-10-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.